Clinical Trial: Randomized, Double-Blind, Placebo-Controlled Clinical Study of Akkermansia on Fat Reduction, Metabolic Improvement, and Safety in Obese Patients (China)

China, Sept. 15 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Randomized, Double-Blind, Placebo-Controlled Clinical Study of Akkermansia on Fat Reduction, Metabolic Improvement, and Safety in Obese Patients'. The following are the other relevant details related to the trial:

Registration Number: ChiCTR2600132364

Registration Time: 2026/09/14

Type: Interventional study

Primary Sponsor: Nanchang Reproductive Hospital

To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=341264

Published by HT Digital Content Services with permission from Health Daily Digest....